Amwell (NYSE: AMWL) product chief sells 2,472 shares in plan

Rhea-AI Filing Summary

American Well Corp Chief Product & Tech. Officer Dmitry Zamansky sold 2,472 shares of Class A common stock in an open-market transaction at $5.45 per share. The trade was executed under a Rule 10b5-1 trading plan adopted on December 1, 2025, leaving him with 196,242 directly owned shares.

Insider Trade Summary

Net Seller: 2,472 shares ($13,472)

Net Sell 1 txn

Insider Zamansky Dmitry

Role Chief Product & Tech. Officer

Sold 2,472 shs ($13K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	2,472	$5.45	$13K

Holdings After Transaction: Class A Common Stock — 196,242 shares (Direct)

Footnotes (1)

1. The sale reported in this Form 4 was effected pursuant to the terms of a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2025. Securities Beneficially Owned includes shares acquired purusant to the Issuer's employee stock purchase plan in transaction exempt under Rule 16b-3.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zamansky Dmitry

(Last) (First) (Middle)

C/O 75 STATE STREET

26TH FLOOR

(Street)

BOSTON MA 02109

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
American Well Corp [ AMWL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product & Tech. Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/02/2026		S(1)		2,472	D	$5.45	196,242(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to the terms of a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2025.

2. Securities Beneficially Owned includes shares acquired purusant to the Issuer's employee stock purchase plan in transaction exempt under Rule 16b-3.

	/s/ Anna Nesterova as attorney-in-fact for Dmitry Zamansky	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AMWL executive Dmitry Zamansky report in this Form 4?

He reported selling 2,472 shares of American Well Class A common stock at $5.45 per share. The transaction was an open-market sale and left him holding 196,242 shares directly after the trade.

Was the AMWL insider sale made under a Rule 10b5-1 plan?

Yes. The filing states the sale was executed under a Rule 10b5-1 trading plan adopted on December 1, 2025. Such plans allow pre-scheduled trades, helping insiders diversify while reducing concerns about trading on material nonpublic information.

How many AMWL shares does Dmitry Zamansky hold after this transaction?

After selling 2,472 shares, he directly owns 196,242 shares of American Well Class A common stock. The filing also notes his beneficial ownership includes shares acquired through the company’s employee stock purchase plan under Rule 16b-3.

What price did the AMWL insider receive for the shares sold?

The reported sale price was $5.45 per share for the 2,472 American Well Class A shares. This reflects the per-share consideration in the open-market transaction disclosed in the Form 4 filed by the company’s Chief Product & Tech. Officer.

Does the Form 4 mention American Well’s employee stock purchase plan?

Yes. A footnote explains that securities beneficially owned include shares acquired through the issuer’s employee stock purchase plan. Those acquisitions were in transactions exempt from Section 16 rules under Rule 16b-3, separate from the reported open-market sale.